Simpore Inc.
West Henrietta, NY Temwindows.com
- UEI
- NYNDZ3F46K36
- CAGE
- 4Q573
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 150 Lucius Gordon Dr #110, West Henrietta, NY 14586, USA
- Website
- simpore.com
- Founded
- 2007
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Rochester | R01EB031581 | $55,804 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Isurtec | Saint Paul, MN | 541713 Research and Development in Nanotechnology |
| Nanosepex Inc. | Bridgewater, NJ | 221310 Water Supply and Irrigation Systems |
| Ardent Process Technologies | New Castle, DE | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Mimetas US Inc. | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Nanofiber Solutions LLC | Dublin, OH | 326199 All Other Plastics Product Manufacturing |
About the company
Simpore Inc. Temwindows.com Division manufactures silicon-based nanomembranes for use in biological microelectromechanical systems and other applications. As a small business, it has received several federal grants to develop and commercialize these technologies.
Simpore has received funding to develop cell culture platforms using its ultrathin silicon membranes for models of tissue barriers like the gut, lung, and vasculature. A 2020 grant from NIH aimed to create commercially viable versions of these platforms. Simpore also received NIH grants related to microplastic contamination testing. A 2019 award supported improved tools to capture and analyze microplastics, including novel silicon microslit filters. Simpore used this funding to scale up production of the filters, automate packaging, and develop peripherals for rapid screening. The company also received a subaward to develop a novel dialyzer membrane for wearable hemodialysis. Through a subcontract with its spin-out Parverio, Simpore is using a 2023 NIH grant to develop a microplastic challenge test as a service for assessing filtration efficiency.
SBA capabilities narrative
Ultra thin membranes, Nanotechnology, Life Sciences
Quick answers
Is Simpore Inc. registered in SAM.gov?
Yes. Simpore Inc.'s SAM.gov registration is active through April 8, 2027.
What is Simpore Inc.'s most recent federal award?
Simpore Inc.'s most recent federal grant award is Commercializing the ?SIM: a modular platform for the development and analysis of barrier tissue models (R44GM137651), from National Institute of General Medical Sciences (NIH), on May 6, 2020.
On GovTribe
See Simpore Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors